Lo-Chlor, L.C. – Trademark Portfolio

Entity Type: 03

Lo-Chlor, L.C. holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 7 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include LO-CHLOR, CHLOR NIX, MIRACLEAR, AQUA BLANKET, and FASTSTART·TECH. The owner is based in Ft. Lauderdale, FL.

5841 Powerline Road

Ft. Lauderdale, FL 33309

9 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Lo-Chlor, L.C.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (7 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Lo-Chlor, L.C. have?

Lo-Chlor, L.C. has 9 U.S. trademarks filed with the USPTO. Of these, 6 registered, 3 cancelled.

What trademark classes does Lo-Chlor, L.C. file in?

Lo-Chlor, L.C. files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are Lo-Chlor, L.C.'s most well-known trademarks?

Lo-Chlor, L.C.'s registered trademark portfolio includes well-known marks such as LO-CHLOR, CHLOR NIX, MIRACLEAR, AQUA BLANKET, and FASTSTART·TECH. These are among 6 currently registered trademarks in the portfolio.

What is Lo-Chlor, L.C.'s trademark registration success rate?

Lo-Chlor, L.C. has a 67% trademark registration rate, with 6 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.